These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2921668)
1. Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity. Van de Wiel PA; Bloksma N; Kuper CF; Hofhuis FM; Willers JM J Pathol; 1989 Jan; 157(1):65-73. PubMed ID: 2921668 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435 [TBL] [Abstract][Full Text] [Related]
3. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice. Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of the toxicity of tumor necrosis factor by tumors in mice. Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K Circ Shock; 1994 Oct; 44(2):77-83. PubMed ID: 7743604 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity. Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044 [TBL] [Abstract][Full Text] [Related]
6. [Damaging action of human recombinant TNF on tumor vessels as an aspect of its anti-neoplastic action against Meth A sarcoma in mice]. Nakamura H; Motoyoshi S; Seto Y; Kadokawa T; Nakata K; Iida M; Taguchi T Gan To Kagaku Ryoho; 1987 Jan; 14(1):91-9. PubMed ID: 3800409 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro. Tomazic VJ; Farha M; Loftus A; Elias EG J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997 [TBL] [Abstract][Full Text] [Related]
8. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system. Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416 [TBL] [Abstract][Full Text] [Related]
9. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice. Manda T; Nishigaki F; Mori J; Shimomura K Cancer Res; 1988 Aug; 48(15):4250-5. PubMed ID: 3390820 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity. Rathjen DA; Ferrante A; Aston R Immunology; 1993 Oct; 80(2):293-9. PubMed ID: 8262557 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo. Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice. Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407 [TBL] [Abstract][Full Text] [Related]
13. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481 [TBL] [Abstract][Full Text] [Related]
14. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF. Inagawa H; Oshima H; Soma G; Mizuno D J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223 [TBL] [Abstract][Full Text] [Related]
15. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Creasey AA; Reynolds MT; Laird W Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916 [TBL] [Abstract][Full Text] [Related]
16. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response. Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805 [TBL] [Abstract][Full Text] [Related]